Concepedia

Wen Jiang

WJ

Statistics

Publications

13

Citations

311

H-Index

12

Active since

2003

Affiliations

Abbott Fund(Current)

Abbott (United States)

Bristol-Myers Squibb (United States)

Abbott (United Kingdom)

Syngene International (India)

Wen Jiang is an author at Abbott Fund specializing in antiviral pharmacology, medicinal chemistry, and enzyme inhibition.

ORCID

Publications per year

2003–2024

13

Publications

13

Mechanistic Study of HCV Polymerase Inhibitors at Individual Steps of the Polymerization Reaction

Yaya Liu, Wen Jiang, John K. Pratt et al. · Biochemistry · 2006 · 43 citations

, , +16

Synthesis and Biological Characterization of B-Ring Amino Analogues of Potent Benzothiadiazine Hepatitis C Virus Polymerase Inhibitors

John T. Randolph, Charles A. Flentge, Peggy Huang et al. · Journal of Medicinal Chemistry · 2009 · 39 citations · Full text

, , +17

Design and Synthesis of Potent, Non-peptide Inhibitors of HCV NS3 Protease

Xiaojun Zhang, Aaron C. Schmitt, Wen Jiang et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 31 citations · Full text

, , +14

Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring

Todd W. Rockway, Rong Zhang, Dachun Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 30 citations · Full text

, , +16

Identification of aryl dihydrouracil derivatives as palm initiation site inhibitors of HCV NS5B polymerase

Yaya Liu, Ben Hock Lim, Wen Jiang et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 28 citations

, , +16

1–5 of 13